CAS 263707-16-0

Formule : C16H15ClN4O2

InChI : InChI=1S/C16H15ClN4O2/c1-16(2,3)14-8-12(21-23-14)15(22)13(9-18)20-19-11-6-4-5-10(17)7-11/h4-8,19H,1-3H3/b20-13+

Code InChI : DXEATJQGQHDURZ-DEDYPNTBSA-N

SMILES : CC(C)(C)C1=CC(=NO1)C(=O)/C(=N/NC2=CC(=CC=C2)Cl)/C#N

ESI-09

CAS : 263707-16-0

ESI-09

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : ≥95%

Masse moléculaire : 330.77

Ref: 54-BUP05730

ESI-09

CAS : 263707-16-0

ESI-09

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : 98%

Masse moléculaire : 330.77

Ref: 54-OR1023846

ESI-09

CAS : 263707-16-0

2-(5-(tert-Butyl)isoxazol-3-yl)-N-(3-chlorophenyl)-2-oxoacetohydrazonoyl cyanide

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : 98%

Masse moléculaire : 330.77

Ref: IN-DG630600

ESI-09

CAS : 263707-16-0

ESI-09 is a new-typel noncyclic nucleotide EPAC antagonist.The IC50 values of ESI-09 for EPAC1 and EPAC2 is 3.2 and 1.4 μM, respectively.

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : 97.24% - 99.57%

Couleur et forme : Solid

Masse moléculaire : 330.769

Ref: TM-T2244

ESI-09

CAS : 263707-16-0

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 330.77

Ref: 10-F547227

ESI 09

Produit contrôlé

CAS : 263707-16-0

Applications ESI 09 acts as an EPAC inhibitor, preventing EPAC-mediated insulin release form β-pancreatic cells. Selective control for EPAC over PKA and decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells.
References Tao, X. et al.: J. Virol., 88, 3902 (2014); Almahariq, M. et al.: Mol. Pharm., 83, 122 (2013);

Formule : C₁₆H₁₅ClN₄O₂

Couleur et forme : Neat

Masse moléculaire : 330.769

Ref: TR-E658950

ESI-09

CAS : 263707-16-0

ESI-09 is a novel drug candidate that has been shown to have synergistic effects with chemotherapeutic agents in the treatment of cancer. It is a potential drug target for cancer, and its anticancer activity may be due to its ability to reduce oxidative stress by activating antioxidant enzymes. ESI-09 has antioxidative properties and decreases the mitochondrial membrane potential, which leads to increased ATP levels. ESI-09 also has the ability to cause cell death by inhibiting aerobic glycolysis, which may be due to its inhibitory effects on the polymerase chain reaction (PCR).

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 330.77 g/mol

Ref: 3D-NKA70716

3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-

CAS : 263707-16-0

Formule : C₁₆H₁₅ClN₄O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 330.7689

Ref: IN-DA002SX8